Back to search

Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients

Data up to Jan 2025

Published1985
Citations73
References32

Total Citations Per Year

Abstract

References (32)

Proposals for the Classification of the Acute Leukaemias F<scp>rench</scp>‐A<scp>merican</scp>‐B<scp>ritish</scp> (FAB) C<scp>o‐operative</scp> G<scp>roup</scp>

1976 • 5,620 citations

Proposals for the classification of the myelodysplastic syndromes

1982 • 3,616 citations

Arabinosyl Cytosine: A Useful Agent in the Treatment of Acute Leukemia in Adults

1968 • 559 citations

Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study

1982 • 521 citations

BREASTFEEDING IN DEVELOPING COUNTRIES

1981 • 374 citations

Acute nonlymphocytic leukemia.A delayed complication of Hodgkin's disease therapy: Analysis of 109 cases

1977 • 227 citations

Different Blocks in the Differentiation of Myeloid Leukemic Cells

1974 • 191 citations

Small doses of ARA‐C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells?

1982 • 189 citations

The Clinical Pharmacology of Antineoplastic Agents

1975 • 181 citations

Does treatment with ARA-C in low dosage cause differentiation of leukemic cells?

1983 • 175 citations

THE DIFFERENTIATION OF MYELOID LEUKAEMIA CELLS: NEW POSSIBILITIES FOR THERAPY

1978 • 162 citations

Induction of differentiation of human myeloid leukemia cells by inhibitors of DNA synthesis.

1982 • 153 citations

Therapy of Secondary Acute Nonlymphocytic Leukemia with Cytarabine

1983 • 133 citations

Second malignancies associated with chemotherapeutic agents.

1982 • 115 citations

Prognostic factors in acute leukemia.

1976 • 112 citations

Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia

1981 • 108 citations

Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia

1981 • 92 citations

Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP)

1981 • 80 citations

QUALITY AND QUANTITY OF SURVIVAL IN ACUTE MYELOID LEUKÆMIA

1975 • 72 citations

Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP)

1981 • 68 citations

Acute Leukemia Over the Age of Fifty: A Study of Its Incidence and Natural History

1956 • 68 citations

Acute myelogenous leukemia subsequent to therapy for a different neoplasm: Clinical features and response to therapy

1977 • 66 citations

Treatment of acute nonlymphocytic leukemia in elderly patients.A prospective study of intensive chemotherapy

1977 • 65 citations

Acute myeloblastic leukemia in elderly patients. Treatment and prognostic factors

1980 • 57 citations

To treat or not to treat acute granulocytic leukemia.

1968 • 50 citations

Treatment of Early Acute Nonlymphatic Leukemia with Low Dose Cytosine Arabinoside

1981 • 50 citations

Variation in Sensitivity of DNA Synthesis to Ara‐C in Acute Myeloid Leukaemia

1980 • 47 citations

The Therapy of Acute Granulocytic Leukemia in Patients More Than Fifty Years Old

1974 • 34 citations

Towards a cure of acute granulocytic leukemia?

1977 • 28 citations

To Treat or Not to Treat Acute Granulocytic Leukemia

1968 • 24 citations

Effect of arabinosyl cytosine on granulopoietic colony formation by marrow cells from leukemic and non-leukemic patients.

1976 • 18 citations

Effect of medium conditioned by acute myeloid leukaemia cells on normal marrow colony-forming ability and sensitivity to cytosine arabinoside

1978 • 7 citations

Cited By (0)

No citing papers found in database

Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly… (1985) – Cancer | Metascience Observatory Explorer